FOX CHASE CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1904-01-01

Employees: -

Market Cap: -

Website: http://www.foxchase.org

Clinical Trials

Study of Ixazomib With Pegylated IFN-alpha 2b (pIFN) in Metastatic Renal Cell Carcinoma (mRCC)

Phase 1

Terminated

Conditions: Metastatic Renal Cell Carcinoma
RCC

Interventions: Drug: Ixazomib
Drug: Pegylated IFN-alpha 2b

First Posted Date: 2015-05-19

Last Posted Date: 2019-09-26

Lead Sponsor: Fox Chase Cancer Center

Target Recruit Count: 3

Registration Number: NCT02447887

Locations: 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

A Web-Based Multimedia Intervention for Head and Neck Cancer Patients

Not Applicable

Completed

Conditions: Cancer of the Head and Neck

Interventions: Behavioral: My Journey AHead

First Posted Date: 2015-05-13

Last Posted Date: 2021-03-17

Lead Sponsor: Fox Chase Cancer Center

Target Recruit Count: 80

Registration Number: NCT02442336

Locations: 🇺🇸
Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States

A Pilot Study of a Home-Based Walking Intervention for Pancreatic Cancer Patients

Not Applicable

Completed

Conditions: Cancer of Pancreas

Interventions: Behavioral: Walking Intervention

First Posted Date: 2015-05-13

Last Posted Date: 2021-01-05

Lead Sponsor: Fox Chase Cancer Center

Target Recruit Count: 50

Registration Number: NCT02442323

Locations: 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

Trial of an Online Multimedia Program to Boost Coping & Function for Prostate Cancer Survivors (PROGRESS)

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Behavioral: PROGRESS

First Posted Date: 2014-08-25

Last Posted Date: 2021-10-12

Lead Sponsor: Fox Chase Cancer Center

Target Recruit Count: 431

Registration Number: NCT02224482

Locations: 🇺🇸
Icahn School of Medicine at Mt Sinai, New York, New York, United States
🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸
Rutgers Cancer Insititute of New Jersey, Somerset, New Jersey, United States

Smoking Cessation for Low-Income Pregnant Women

Not Applicable

Completed

Conditions: Smoking
Pregnancy

Interventions: Behavioral: Best Practice (BC) Control
Behavioral: Cognitive-Behavioral Counseling (CBC)

First Posted Date: 2014-08-07

Last Posted Date: 2014-08-07

Lead Sponsor: Fox Chase Cancer Center

Target Recruit Count: 277

Registration Number: NCT02211430

Locations: 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

Leukemia SPORE Phase II DAC Study for R/R and Elderly Acute AML and MDS

Phase 2

Completed

Conditions: Acute Myeloid Leukemia
Chronic Myelomonocytic Leukemia
Myelodysplastic Syndrome

Interventions: Drug: Decitabine
Drug: Carboplatin
Drug: Arsenic trioxide

First Posted Date: 2014-07-15

Last Posted Date: 2021-05-19

Lead Sponsor: Fox Chase Cancer Center

Target Recruit Count: 92

Registration Number: NCT02190695

Locations: 🇺🇸
Temple BMT Program at Jeanes Hospital, Philadelphia, Pennsylvania, United States
🇺🇸
M.D. Anderson Cancer Center, Houston, Texas, United States

A Tailored Internet Intervention to Reduce Skin Cancer Risk Behaviors Among Young Adults

Not Applicable

Completed

Conditions: Skin Neoplasms

Interventions: Behavioral: UV4me
Behavioral: Skin Cancer Foundation website

First Posted Date: 2014-05-26

Last Posted Date: 2018-07-03

Lead Sponsor: Fox Chase Cancer Center

Target Recruit Count: 1234

Registration Number: NCT02147080

Locations: 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

Comparative Effectiveness of CTC & OC

Completed

Conditions: Colorectal Cancer

First Posted Date: 2014-05-20

Last Posted Date: 2016-11-30

Lead Sponsor: Fox Chase Cancer Center

Target Recruit Count: 244

Registration Number: NCT02143115

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 2 locations

Genetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Advanced Rectal Cancer Undergoing Chemoradiation

Completed

Conditions: Signet Ring Adenocarcinoma of the Rectum
Stage IIC Rectal Cancer
Stage IIIA Rectal Cancer
Recurrent Rectal Cancer
Stage IIIB Rectal Cancer
Stage IIB Rectal Cancer
Mucinous Adenocarcinoma of the Rectum
Stage IIA Rectal Cancer
Stage IIIC Rectal Cancer

Interventions: Other: cytology specimen collection procedure
Other: laboratory biomarker analysis

First Posted Date: 2014-05-07

Last Posted Date: 2024-05-02

Lead Sponsor: Fox Chase Cancer Center

Target Recruit Count: 43

Registration Number: NCT02132858

Locations: 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

Not Applicable

Terminated

Conditions: Malignant Pericardial Effusion
Malignant Pleural Effusion
Recurrent Non-small Cell Lung Cancer
Stage IIIB Non-small Cell Lung Cancer
Stage IV Non-small Cell Lung Cancer

Interventions: Procedure: therapeutic procedure
Other: cytology specimen collection procedure
Other: laboratory biomarker analysis
Drug: targeted therapy

First Posted Date: 2014-05-07

Last Posted Date: 2019-09-04

Lead Sponsor: Fox Chase Cancer Center

Target Recruit Count: 1

Registration Number: NCT02132884

Locations: 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy